<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>98(50)</volume><submitter>Gaujoux S</submitter><pubmed_abstract>&lt;h4>Rationale&lt;/h4>Intraductal papillary and mucinous neoplasms of the pancreas (IPMN) are preneoplastic lesions diagnosed with an increasing incidence. Recently, several groups have described, in up to 70% of IPMN, activating mutations of the G-protein alpha stimulatory sub-unit (Gsα subunit) gene (GNAS). GNAS-activating somatic, post-zygotic, mutations are also associated with McCune-Albright syndrome (MCAS) characterized by fibrous dysplasia, precocious puberty, and café-au-lait spots.&lt;h4>Patient concerns&lt;/h4>We herein report a patient with McCune Albright Syndrome that presented with malignant IPMN and underwent pancreatic resection.&lt;h4>Diagnoses and interventions&lt;/h4>Leucocyte and duodenum juice DNA analysis, endoscopically collected from secretin-stimulated pancreatic juice revealed the same (GNAS) activating mutation also found in the invasive pancreatic colloid adenocarcinoma arising from intestinal subtype IPMN.&lt;h4>Outcomes&lt;/h4>Thirty months after surgery, the patient was alive with recurrence (bone only metastasis).&lt;h4>Lessons&lt;/h4>In this observation, we show that MCAS should be view as a new genetic predisposition to IPMN associated pancreatic cancer, and consequently a targeted screening in this high-risk population might be proposed.</pubmed_abstract><journal>Medicine</journal><pagination>e18102</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6922479</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.</pubmed_title><pmcid>PMC6922479</pmcid><pubmed_authors>Silve C</pubmed_authors><pubmed_authors>Leroy K</pubmed_authors><pubmed_authors>Douset B</pubmed_authors><pubmed_authors>Mehsen-Cetre N</pubmed_authors><pubmed_authors>Coriat R</pubmed_authors><pubmed_authors>Gaujoux S</pubmed_authors><pubmed_authors>Prat F</pubmed_authors><pubmed_authors>Pasmant E</pubmed_authors><pubmed_authors>Rouquette A</pubmed_authors></additional><is_claimable>false</is_claimable><name>McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.</name><description>&lt;h4>Rationale&lt;/h4>Intraductal papillary and mucinous neoplasms of the pancreas (IPMN) are preneoplastic lesions diagnosed with an increasing incidence. Recently, several groups have described, in up to 70% of IPMN, activating mutations of the G-protein alpha stimulatory sub-unit (Gsα subunit) gene (GNAS). GNAS-activating somatic, post-zygotic, mutations are also associated with McCune-Albright syndrome (MCAS) characterized by fibrous dysplasia, precocious puberty, and café-au-lait spots.&lt;h4>Patient concerns&lt;/h4>We herein report a patient with McCune Albright Syndrome that presented with malignant IPMN and underwent pancreatic resection.&lt;h4>Diagnoses and interventions&lt;/h4>Leucocyte and duodenum juice DNA analysis, endoscopically collected from secretin-stimulated pancreatic juice revealed the same (GNAS) activating mutation also found in the invasive pancreatic colloid adenocarcinoma arising from intestinal subtype IPMN.&lt;h4>Outcomes&lt;/h4>Thirty months after surgery, the patient was alive with recurrence (bone only metastasis).&lt;h4>Lessons&lt;/h4>In this observation, we show that MCAS should be view as a new genetic predisposition to IPMN associated pancreatic cancer, and consequently a targeted screening in this high-risk population might be proposed.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-04T22:29:41.911Z</modification><creation>2020-05-22T08:23:06Z</creation></dates><accession>S-EPMC6922479</accession><cross_references><pubmed>31852070</pubmed><doi>10.1097/MD.0000000000018102</doi></cross_references></HashMap>